Therapeutic Targets Database
BIDD Pharmainformatics Databases


TTD Target ID: TTDR00420

Target Information
NameOxysterols receptor LXR-alpha    
Type of targetResearch target    
Liver X receptor alpha    
Nuclear orphan receptor LXR-alpha    
Nuclear receptor LXRalpha    
[ICD9: 414.0, 440   ICD10: I70]
Cancer, unspecific
[ICD9: 140-229   ICD10: C00-C96]
BioChemical ClassZinc-finger    
PathwayPPAR signaling pathway
UniProt IDQ13133
PDB Structure1UHL.    
FunctionOrphan receptor. Interaction with rxr shifts rxr from its role as a silent dna-binding partner to an active ligand- binding subunit in mediating retinoid responses through target genes defined by lxres. Lxres are dr4-type response elements.    
Target ValidationClick to Find Target Validation Information.    
Inhibitor12,17-dehydroxyriccardin C[3]
12-dehydroxyriccardin C[3]
17-dehydroxyriccardin C[3]
2- (2-hexylphenyl)isoindoline-1,3-dione[3]
2- (2-phenethylphenyl)isoindoline-1,3-dione[4]
2-Benzyl-3-phenyl-7- (trifluoromethyl)-2H-indazole[5]
4,12,17-dehydroxyriccardin C[3]
4,17-dehydroxyriccardin C[3]
4-dehydroxyriccardin C[3]
5-chloro-2- (4-phenylbutyl)isoindoline-1,3-dione[6]
Guttiferone I[8]
N-{4-[2- (3-Hydroxyphenyl)ethyl]phenyl}phthalimide[4]
N-{4-[2- (3-Methoxyphenyl)ethyl]phenyl}phthalimide[4]
N-{4-[2- (4-Hydroxyphenyl)ethyl]phenyl}phthalimide[4]
N-{4-[2- (4-Methoxyphenyl)ethyl]phenyl}phthalimide[4]
riccardin C[3]
Cross References 3D Structure
Related Literature
On-Line Medical Dictionary
Ref 1A novel liver X receptor agonist establishes species differences in the regulation of cholesterol 7alpha-hydroxylase (CYP7a). Endocrinology. 2002 Jul;143(7):2548-58. To Reference
Ref 2The nuclear receptors FXR and LXRalpha: potential targets for the development of drugs affecting lipid metabolism and neoplastic diseases. Curr Pharm Des. 2001 Mar;7(4):231-59. To Reference
Ref 3Bioorg Med Chem. 2008 Apr 15;16(8):4272-85. Epub 2008 Feb 29.Co-existence of alpha-glucosidase-inhibitory and liver X receptor-regulatory activities and their separation by structural development. To Reference
Ref 4Bioorg Med Chem. 2009 Jul 15;17(14):5001-14. Epub 2009 Jun 2.Separation of alpha-glucosidase-inhibitory and liver X receptor-antagonistic activities of phenethylphenyl phthalimide analogs and generation of LXRalpha-selective antagonists. To Reference
Ref 5J Med Chem. 2008 Nov 27;51(22):7161-8.Indazole-based liver X receptor (LXR) modulators with maintained atherosclerotic lesion reduction activity but diminished stimulation of hepatic triglyceride synthesis. To Reference
Ref 6Bioorg Med Chem Lett. 2007 Jul 15;17(14):3957-61. Epub 2007 Apr 30.Liver X receptor antagonists with a phthalimide skeleton derived from thalidomide-related glucosidase inhibitors. To Reference
Ref 7J Med Chem. 2008 Sep 25;51(18):5758-65.Structure-guided design of N-phenyl tertiary amines as transrepression-selective liver X receptor modulators with anti-inflammatory activity. To Reference
Ref 8J Nat Prod. 2005 Apr;68(4):617-9.Guttiferone I, a new prenylated benzophenone from Garcinia humilis as a liver X receptor ligand. To Reference
Ref 9Bioorg Med Chem. 2009 May 15;17(10):3519-27. Epub 2009 Apr 12.Discovery and SAR of cinnolines/quinolines as liver X receptor (LXR) agonists with binding selectivity for LXRbeta. To Reference
Ref 10Bioorg Med Chem. 2009 Dec 1;17(23):8086-92. Epub 2009 Oct 4.4-(3-aryloxyaryl)quinoline alcohols are liver X receptor agonists. To Reference


Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.

Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links


Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543